January 2019 - Volume 7 - Issue 1 - p e2079 | English
Plastic Reconstructive Surgery - Global OpenYan Wu, Gang Wang, Chengxin Li, Cheri Mao, Xianofang Lei, Elisabeth Lee
Original article
Plastic Reconstructive Surgery - Global OpenThe use of botulinum toxin injections for minimally invasive facial aesthetic procedures has become common worldwide, with more than 4.6 million procedures performed in 2015. OnabotulinumtoxinA (Botox Cosmetic; Allergan plc, Dublin, Ireland) is approved for the treatment of glabellar lines in more than 75 countries and crow’s feet lines (CFL) in more than 55 countries.
Sign in or register for free to read the full article